Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Angel homolog 1 (ANGEL1) is a member of the CCR4 deadenylase family and serves as a modulator of post-transcriptional gene regulation, with specialized binding activity to eukaryotic initiation factor 4E (eIF4E). ANGEL1 is localized in various cellular compartments such as the endoplasmic reticulum, cis-Golgi network, perinuclear region, and mitochondrial outer membrane. It plays a role in selective mRNA stability regulation rather than general protein synthesis. Experimental evidence indicates that peptides derived from its eIF4E-binding motif can induce necrotic cell death specifically in epithelial cancer cell lines, positioning ANGEL1 as a candidate for targeted anti-cancer strategies. The gene is also associated with familial arrhythmogenic right ventricular dysplasia, but its primary molecular role centers on mRNA metabolism. ANGEL1 is evolutionarily conserved and grouped with other deadenylases such as PARN and Nocturnin, and its functions extend to fine-tuning gene expression at the post-transcriptional level.
Peptide derived from ANGEL1 induces rapid necrotic cell death, likely via inhibition or disruption of eIF4E interaction and post-transcriptional mRNA regulation. Broadly, modulation of deadenylase activity leading to altered mRNA stability.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Angel homolog 1 (ANGEL1).